Skip to Main Content

Paper Details

Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection.
medRxiv
55
2021
BNT162b2 mRNA, BioNTech mRNA vaccine, COVID-19, Cancer, Human, SARS, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 IgG, SARS-CoV-2 IgG antibodies, SARS-CoV-2 IgG antibody, SARS-CoV-2 virus, convalescent, mRNA vaccine, patients
Author NameAffiliation
Ariel IsraelLeumit Research Institute & Department of Family Medicine, Leumit Health Services
Alejandro A Sch??fferNational Cancer Institute
Eytan RuppinNational Cancer Institute
  • 1 - 3

Datasets

Release 1.2